BOSTON–Atrandi Biosciences, a pioneering life sciences company transforming single-cell analysis with its patented Semi-Permeable Capsule (SPC) technology, will present its latest developments at the American Society of Human Genetics (ASHG) 2025 Annual Meeting, taking place October 14–18 in Boston. Attendees are invited to explore how SPCs are reshaping single-cell multiomics at booth #2402. “The Atrandi […]
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, today announced a multi-year collaboration. Together, BD and Opentrons will integrate robotic liquid-handling capabilities into BD single-cell multiomics instruments, automating critical […]
Takara Bio USA, Inc. (“Takara Bio USA”), a wholly owned subsidiary of Takara Bio Inc. (“Takara Bio”), today announced a series of updates to its spatial biology product portfolio, extending its innovation with a new class of spatial technology. Takara Bio USA has expanded its instrument-free Trekker™ Single-Cell Spatial Mapping Kits for compatibility with formalin-fixed […]
FREDERICK, Md. and PLANO, Texas — RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and Secretome Therapeutics, a clinic-stage company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC), today announced completion of commercial scale production of Secretome’s lead nCPC, STM-01. In March 2025, […]
Anticipated collaboration with leading academic institutions aims to overcome key barriers in cell and gene therapy by targeting solid tumors, enabling in vivo treatment, and radically reducing manufacturing costs Cytiva (Global Life Sciences Solutions USA, LLC), a Danaher company and a global leader in the life sciences industry, will lead a new effort aiming to […]
Caption: TheraPEAK 293-GT media system for suspension HEK203 cell lines. Caption: TheraPEAK AmpliCell Recombinant Interleukin Cytokines. AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing TheraPEAK® 293-GT® Medium System aims to help accelerate development timelines and improve consistency from research through to GMP gene therapy production Basel, Switzerland […]
MaxCyte’s Flow Electroporation® Technology will support efficient gene delivery to advance Moonlight Bio’s engineered T cell therapies ROCKVILLE, Md. — MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics, today announced the signing of a Strategic Platform License (SPL) agreement with […]
• AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing • TheraPEAK® 293-GT® Medium System aims to help accelerate development timelines and improve consistency from research through to GMP gene therapy production Basel, Switzerland – Life Science Newswire – Lonza, one of the world’s largest contract development and manufacturing […]
Brings more than three decades of leadership experience in the life sciences industry RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the appointment of Gregory T. Lucier to its Board of Directors. Mr. Lucier brings […]
LIVERMORE, Calif. — Precision Cell Systems (PCS) today announced the acquisition of BennuBio, marking a significant entry into the rapidly growing 3D cell culture market. According to Grand View Research, the global market was valued at over $1.7 billion and is projected to exceed $3.2 billion by 2030. The acquisition brings BennuBio’s Velocyt™ imaging flow […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
